Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach.
Publication/Presentation Date
8-1-2020
Abstract
Intraarterial chemotherapy (IAC) for retinoblastoma has notably changed the natural history of the disease and stands as an encouraging example of selective drug delivery. Targeted drug delivery allows achieving a high drug concentration within target tissue along with low systemic concentration. This maintains a high safety profile along with a high efficacy rate (97%).1-4 Increasing experience, refinements of the technique, and positive results of IAC over the past decade have expanded the indications to deliver treatment to a larger population. The most recent improvement introduced in our practice was administering the therapy using the transradial approach. Herein, we demonstrate the technique for IAC using both the transradial and transfemoral approach (video 1).
Volume
12
Issue
8
First Page
828
Last Page
828
ISSN
1759-8486
Published In/Presented At
Sweid, A., & Jabbour, P. (2020). Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery, 12(8), 828. https://doi.org/10.1136/neurintsurg-2019-015627
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32414893
Department(s)
Administration and Leadership
Document Type
Article